Status:
UNKNOWN
Reversal of a Defunctioning Ileostomy 3 Weeks After the Index Operation, RCT
Lead Sponsor:
National Cancer Institute, Egypt
Conditions:
Colo-rectal Cancer
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
Diverting ileostomy seems to mitigate the consequences of anastomotic leak from low rectal anastomosis. Gastrointestinal continuity is restored after a period of 6-12 weeks but it can be longer if the...
Detailed Description
All consecutive patients coming to National Cancer Institute of Cairo university, having a defunctioning ileostomy during a low rectal or anal anastomosis or even for obstructive purposes, will be con...
Eligibility Criteria
Inclusion
- All patients who have a defunctioning ileostomy after a colorectal surgery
Exclusion
- When performed to cover unsatisfactory anastomosis
- Positive air-leak test
- Those experienced postoperative complications
- Those with preoperative (1st operation) albumin below 3.5gm/dL.
- Immunocompromised patients e.g on steroids or have uncontrolled DM.
Key Trial Info
Start Date :
December 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 25 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05192018
Start Date
December 25 2021
End Date
July 25 2023
Last Update
January 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute
Cairo, Egypt, 11796